Professional Medical Expertise Company Income Statement

Financials in millions SAR. Fiscal year is January - December.

Millions SAR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '23 Dec 31, 2023	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	250.12	250.12	176.05	131.26	74.42
Revenue Growth (YoY)	42.07%	42.07%	34.12%	76.38%	-
Cost of Revenue	138.15	138.15	92.4	64.35	34.62
Gross Profit	111.96	111.96	83.65	66.91	39.8
Selling, General & Admin	75.83	75.83	55.24	42.02	27.65
Operating Expenses	78.62	78.62	57.64	42.46	28.15
Operating Income	33.34	33.34	26.01	24.45	11.65
Other Non Operating Income (Expenses)	-6.13	-6.13	-5.14	-2.64	-1.64
Pretax Income	27.22	27.22	20.87	21.81	10
Income Tax Expense	2.37	2.37	1.85	1.19	0.71
Earnings From Continuing Operations	24.84	24.84	19.02	20.62	9.3
Minority Interest in Earnings	-0	-0	-	-	-
Net Income	24.84	24.84	19.02	20.62	9.3
Net Income to Common	24.84	24.84	19.02	20.62	9.3
Net Income Growth	30.65%	30.65%	-7.78%	121.80%	-
Shares Outstanding (Basic)	4	4	2	1	-
Shares Outstanding (Diluted)	4	4	2	1	-
Shares Change (YoY)	56.73%	56.73%	189.51%	-	-
EPS (Basic)	7.10	7.10	8.52	26.73	-
EPS (Diluted)	7.10	7.10	8.52	26.73	-
EPS Growth	-16.64%	-16.64%	-68.15%	-	-
Free Cash Flow	-3.1	-3.1	-10.43	17.69	9.93
Free Cash Flow Per Share	-0.89	-0.89	-4.67	22.93	-
Gross Margin	44.76%	44.76%	47.51%	50.98%	53.48%
Operating Margin	13.33%	13.33%	14.77%	18.63%	15.65%
Profit Margin	9.93%	9.93%	10.80%	15.71%	12.49%
Free Cash Flow Margin	-1.24%	-1.24%	-5.93%	13.48%	13.35%
EBITDA	37.34	37.34	28.07	26.25	13.26
EBITDA Margin	14.93%	14.93%	15.94%	20.00%	17.82%
D&A For EBITDA	3.99	3.99	2.06	1.79	1.62
EBIT	33.34	33.34	26.01	24.45	11.65
EBIT Margin	13.33%	13.33%	14.77%	18.63%	15.65%
Effective Tax Rate	8.72%	8.72%	8.88%	5.46%	7.07%

Source: S&P Capital IQ. Standard template. Financial Sources.